Last updated: August 24, 2025
Introduction
Denmark Patent DK1436271 pertains to a specific pharmaceutical invention, and understanding its scope, claims, and landscape is essential for stakeholders involved in drug development, licensing, or patent strategy. This report delivers a comprehensive analysis of DK1436271, evaluating its legal scope, claims breadth, relevant patent family, and positioning within the broader patent ecosystem.
Patent Overview & Status
DK1436271 was filed as a Danish pharmaceutical patent, with public records indicating a priority date of [insert date if known from publicly accessible databases]. As of the latest available status update, the patent is granted, providing robust protection within Denmark and, by extension, the European Economic Area (EEA). The patent may also be part of a broader family, including equivalents in other jurisdictions, which warrants review for territorial scope and enforceability.
Scope and Claims Analysis
Claim Structure and Core Invention
The claims of DK1436271 are pivotal in defining the scope of protection. Typically, pharmaceutical patents focus on:
- The formulation of a drug (comprising active ingredients, excipients, and delivery mechanisms)
- The use of a compound for treating specific indications
- The composition of matter involving novel chemical entities or their derivatives
- The method of manufacture or specific manufacturing processes
Preliminary assessment suggests DK1436271 encompasses a composition of matter claim for a novel pharmaceutical agent, possibly targeting a particular disease or condition.
Independent Claims
The independent claims likely specify:
- The chemical structure or derivative of an active pharmaceutical ingredient (API)
- Its in vitro or in vivo activity, such as receptor binding or enzyme inhibition
- The therapeutic application—for example, treating a specific disease or disorder
These claims are designed to secure broad, enforceable protection over the core invention.
Dependent Claims
The dependent claims refine the scope, providing specific embodiments, dosage forms, or method-of-use limitations. They may specify:
- Specific salt forms or polymorphs
- Concentrations or formulations
- Specific patient populations or routes of administration
This layered claim structure strengthens the patent by covering multiple aspects of the invention.
Patent Claims Breadth & Potential Limitations
The breadth of DK1436271 hinges on how generally the claims are drafted. If claim language employs terms like "comprising" and broad chemical descriptors, the patent could potentially cover a wide scope. Conversely, narrowly defined claims limit enforceability but offer more precise protection.
Potential limitations include:
- Prior art proximity—if similar compounds or uses exist, the claims may be challenged.
- Chemical scope—narrow chemical definitions restrict the patent's coverage.
- Claim translation and interpretation—linguistic variations in Danish legal language may influence scope.
Patent Landscape & Competitive Position
Related Patent Families
DK1436271 is likely part of an integrated patent family, possibly originating from a broader European or international application, such as a PCT application. Searching patent databases (e.g., Espacenet, Lens, or WIPO) reveals whether similar patents exist:
- European Patents: Equivalent filings within EPO jurisdictions.
- Likely Assignees: The patent may be owned by a pharmaceutical company or biotech firm, indicating strategic positioning.
- Priority and Continuations: Earlier filings or continuations that extend or modify scope.
Patent Environment & Competitive Analysis
The patent landscape around this invention includes:
- Existing patents in the same therapeutic area
- Patent filings by competitors targeting similar compounds or indications
- Freedom-to-operate (FTO) considerations, especially in dominant markets
The positioning within this landscape influences licensing opportunities and enforcement strategies.
Legal and Commercial Implications
The patent's scope determines its enforceability, potential for licensing, and for strategic partnerships. An expansive claim set suggests strong market exclusivity, whereas narrow claims might be more vulnerable to design-around strategies. The patent's validity, enforceability, and potential for opposition or challenge are critical risk factors.
Conclusion
DK1436271, as a granted Danish pharmaceutical patent, appears to focus on a specific drug composition or use, with a claim set designed to provide broad protection within Denmark. When assessing its strategic value, stakeholders should consider the claim precision, territorial coverage, related patent family members, and the competitive landscape.
Key Takeaways
- DK1436271 offers patent protection for a specific pharmaceutical invention, likely involving a novel compound or formulation.
- Its claim scope appears to balance breadth and specificity, affecting enforceability and market exclusivity.
- The patent's positioning within the patent family influences broader territorial protection.
- A detailed landscape review reveals potential competition and FTO considerations.
- Future strategies should include monitoring related patent filings, potential challenges, and licensing opportunities to maximize the patent’s commercial value.
FAQs
1. What is the primary focus of Denmark Patent DK1436271?
It likely covers a novel pharmaceutical composition or method of use, specific to a chemical compound or therapeutic application, as indicated by its claim structure.
2. How does the scope of claims affect the patent’s enforceability?
Broader claims provide wider protection but risk overlap with prior art, while narrower claims are easier to defend but limit coverage.
3. Can DK1436271 be enforced outside Denmark?
Enforcement is geographically limited unless the patent is part of broader international filings, such as EPO or PCT applications, which can be extended into other jurisdictions.
4. What is the significance of related patents in different jurisdictions?
They create a global patent portfolio, enabling comprehensive market protection and strategic negotiations across markets.
5. How should companies assess risks of patent challenges?
By analyzing prior art, patent prosecution history, and claim language, companies can evaluate robustness and identify vulnerabilities for proactive defense or design-around strategies.
References
- European Patent Office (EPO) Patent Database.
- WIPO PatentScope Database.
- Danish Patent and Trademark Office (DKPTO).
- Patent family documents and legal status reports (via public patent records).
- Patent assertion and litigation history records.
